While becoming upregulated, NKILA binds to NF-κB and represses its activity on downstream anti-apoptotic target genes, thus forcing effector CD8+ T cells to undergo AICD and tumor cells to escape CTL-mediated cytotoxicity [46]. Here, NFKB1 is linked to neoplasm.